Literature DB >> 30561903

Patients with cystic fibrosis having a residual function mutation: Data from the Italian registry.

Donatello Salvatore1, Rita Padoan2, Roberto Buzzetti3, Annalisa Amato4, Barbara Giordani4,5, Gianluca Ferrari4, Fabio Majo4,6.   

Abstract

BACKGROUND: CFTR mutations permitting residual function (RF) of the CFTR protein are disease-causing. These mutations are associated with a pneumopathy that is delayed in onset and is slower in progression than are more common forms of cystic fibrosis (CF), although the disease may become severe in some patients. RF mutations are among the most frequent in Italy, thus encouraging investigation of their prevalence and associated phenotypes.
METHODS: Data from the Italian Registry were used to compare patients with at least one RF mutation with those homozygous for F508del.
RESULTS: A total of 806 patients bearing at least one RF mutation were identified among 5204 registered patients (15.5%). The RF patients were older than the F508del homozygotes (median age 26.0 years vs 19.8 years, respectively), with a higher median age at diagnosis (6.3 years vs 0.2 years, respectively) and a lower median sweat chloride value (76.0 mmol/L vs 100.0 mmol/L, respectively). In the RF group, lung infections and comorbidities were less prevalent than those in the F508del homozygotes, while better FEV1 and nutritional status were observed at all ages. Within the RF group, RF/F508del subjects showed more severe pneumopathy than did patients with RF/other mutations. In particular, the 3849 + 10kbC → T/F508del subjects had worse FEV1 and a higher prevalence of lung infections than did patients with other genotypes.
CONCLUSIONS: Patients with RF mutations are numerous in Italy and have a milder disease phenotype than do F508del homozygotes. Inside the RF group, F508del heterozygotes and, in particular, 3849 + 10kbC → T/F508del patients showed more severe pneumopathy.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  CFTR with residual function mutations; cystic fibrosis; epidemiology; patient registry

Mesh:

Substances:

Year:  2018        PMID: 30561903     DOI: 10.1002/ppul.24215

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  2 in total

1.  Analysis of the genotypic profile and its relationship with the clinical manifestations in people with cystic fibrosis: study from a rare disease registry.

Authors:  Senay Rueda-Nieto; Pedro Mondejar-Lopez; María-Pilar Mira-Escolano; Ana Cutillas-Tolín; Luis Alberto Maceda-Roldán; Julián Jesús Arense-Gonzalo; Joaquín A Palomar-Rodríguez
Journal:  Orphanet J Rare Dis       Date:  2022-06-13       Impact factor: 4.303

2.  CRMS/CFSPID Subjects Carrying D1152H CFTR Variant: Can the Second Variant Be a Predictor of Disease Development?

Authors:  Vito Terlizzi; Rita Padoan; Laura Claut; Carla Colombo; Benedetta Fabrizzi; Marco Lucarelli; Sabina Maria Bruno; Alice Castaldo; Paolo Bonomi; Giovanni Taccetti; Antonella Tosco
Journal:  Diagnostics (Basel)       Date:  2020-12-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.